Overview
This focused, three‑hour virtual pre‑conference brings together practical, evidence‑based guidance for clinicians who care for patients with skin of color (SOC). Through concise expert presentations and case‑based discussions, participants will learn real‑world strategies for initiating and switching systemic therapies, recognize SOC‑specific presentations and pigmentary sequelae, integrate comorbidity screening and shared decision‑making into long‑term care, and apply pediatric‑focused approaches to counseling families. Sessions will be led by world‑renowned dermatology experts in skin of color, pediatric dermatology, and systemic therapeutics.
What to Expect
- Practical algorithms and one‑page clinical tools for initiating and switching biologics and small molecules in atopic dermatitis and psoriasis.
- SOC‑specific insights on presentation differences, dyspigmentation prevention and management, and expectations for pigmentary recovery.
- Pediatric‑focused guidance on dosing, safety, vaccination and growth counseling, family‑centered adherence tactics, and resources for prior authorization.
- A concise comorbidity screening checklist and workflows for multidisciplinary referral and shared decision‑making.
- Interactive Q&A with world‑renowned dermatology experts.
Co-Chairs
Andrew F. Alexis, MD, MPH, FAAD
Professor of Clinical Dermatology Vice-Chair for Diversity and Inclusion Weill Cornell Medicine New York, New York
Eliot F. Battle, MD
CEO and Co-Founder Cultura Dermatology & Plastic Surgery Washington, District of Columbia
Faculty
Adelaide A. Hebert, MD, FAAD
Chief of Pediatric Dermatology UTHealth McGovern Medical School-Houston and Children’s Memorial Hermann Hospital-Houston Houston, Texas
George Han, MD, PhD
Associate Professor Department of Dermatology Zucker School of Medicine at Hofstra/Northwell Hofstra University Hempstead, New York
Mercedes E. Gonzalez, MD, FAAD
Assistant Professor Department of Dermatology Florida International University Herbert Wertheim School of Medicine University of Miami Miller School Medicine Pediatric Dermatologist DERM360 Director Pediatric Skin Research Miami, Florida
Raj J. Chovatiya, MD, PhD, MSCI, FAAD
Clinical Associate Professor Rosalind Franklin University Chicago Medical School Founder and Director Center for Medical Dermatology and Immunology Research Chicago, Illinois
Agenda
Please note all sessions listed in Eastern Time. Agenda and credit amount are subject to change.
Tuesday, August 11
6:00 pm — 7:00 pm
Session I: Biologics and Beyond in Atopic Dermatitis: Real‑World Strategies for Initiation, Switching, and Long‑Term Care
Tuesday, August 11
6:00 pm — 6:05 pm
Symposium Welcome and Session Introduction
Tuesday, August 11
6:05 pm — 6:25 pm
How to Initiate Therapies and Choose Algorithms for Moderate to Severe Atopic Dermatitis in Patients With Skin of Color
Tuesday, August 11
6:25 pm — 6:45 pm
Pediatric Atopic Dermatitis in Skin of Color—When to Start Systemic Therapy and How to Counsel Families
Tuesday, August 11
6:45 pm — 7:00 pm
Panel Discussion & Audience Q&A
Raj J. Chovatiya, MD, PhD, MSCI, FAAD
Mercedes E. Gonzalez, MD, FAAD
Tuesday, August 11
7:00 pm — 8:00 pm
Non-CME/CE Bonus Presentation
Tuesday, August 11
8:00 pm — 9:00 pm
Session II: Psoriasis in Practice — Precision Therapy, Comorbidity Screening, and Shared Decision‑Making
Tuesday, August 11
8:00 pm — 8:05 pm
Session Introduction
Tuesday, August 11
8:05 pm — 8:25 pm
Precision Selection of Systemic Therapy for Psoriasis in Patients With Skin of Color
Tuesday, August 11
8:25 pm — 8:45 pm
Pediatric Psoriasis in Skin of Color — Early Recognition, Treatment Thresholds, and Family Counseling
Tuesday, August 11
8:45 pm — 9:00 pm
Panel Discussion & Audience Q&A
Eliot F. Battle, MD
George Han, MD, PhD, FAAD
Adelaide A. Hebert, MD, FAAD
Accreditation
TARGET AUDIENCE
This activity is intended for Dermatologists, Dermatology Residents/Fellows, Physician Assistants, Nurse Practitioners, Nurses, and other health professionals interested in treating patients with dermatologic diseases.
LEARNING OBJECTIVES
As a result of participating in this activity, participants should be better able to: [LIST][ITEM]Differentiate skin color classification systems to categorize common skin disorders and cutaneous diseases in patients with skin of color [ITEM]Evaluate key differences in the skin structure and how it relates to diagnosing and treating common ethnic skin disorders such as atopic dermatitis, psoriasis, hidradenitis suppurativa, alopecia areata, and vitiligo. [ITEM]Identify clinical and diagnostic tools and devices utilized in the diagnosis and management of skin disorders for patients with skin color. [ITEM]Apply confidence in their ability to communicate effectively and work as part of the interprofessional team to optimize patient care
ACCREDITATION STATEMENTS
[JALOGOGAME] In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and National Medical Education Corporation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[underline]Credit Designation[/underline] [underline]Physician Continuing Medical Education[/underline] The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credits™.[/italic] Physicians should claim only the credit commensurate with the extent of their participation in the activity. [underline]Continuing Nursing Education [/underline] The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined. [AAPA] [underline]Continuing Physician Assistant Education [/underline] Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. [underline]Interprofessional Continuing Education [/underline] [ICPE] This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credit for learning and change.